Form 8-K - Current report:
SEC Accession No. 0001437749-26-004542
Filing Date
2026-02-18
Accepted
2026-02-18 16:01:20
Documents
14
Period of Report
2026-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio20260216_8k.htm   iXBRL 8-K 25280
2 EXHIBIT 10.1 ex_921338.htm EX-10.1 9983
  Complete submission text file 0001437749-26-004542.txt   172236

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA phio-20260218.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phio-20260218_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE phio-20260218_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phio-20260218_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT phio20260216_8k_htm.xml XML 2960
Mailing Address 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406
Business Address 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

EIN.: 453215903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 26648066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)